Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- RA Patients Criticized as Selfish, Lazy: Wyeth Survey
January 12, 2004
- BULLETIN
January 12, 2004
- Pharmacokinetic Frequency Analysis Database Jointly Developed by PSC, JBIC
January 12, 2004
- FJPWA Petitions Korosho Regarding Joint Purchasing
January 12, 2004
- DIAGNOSTIC NEWS IN BRIEF
January 12, 2004
- Council Supports Inspection, Payment of Dispensing Bills by Insurers
January 12, 2004
- MEDICAL DEVICE NEWS IN BRIEF
January 12, 2004
- Monkasho Facing 4.5% Budget Cut in FY2004
January 12, 2004
- JACDS to Create Certification System for Kampo Advisors
January 12, 2004
- NEW PRODUCTS
January 12, 2004
- Wholesalers' Profits May Fall 30% This Fiscal Year: Mr Kimura of CR&C
December 29, 2003
- MEDICAL DEVICE NEWS IN BRIEF
December 29, 2003
- FPMAJ to Introduce Bar Code System Starting from Bio-derived Products
December 29, 2003
- WORLD NEWS IN BRIEF
December 29, 2003
- Quintiles' CSO Business Growing Rapidly
December 29, 2003
- The Value of New Medicines
December 29, 2003
- BUSINESS NEWS IN BRIEF
December 29, 2003
- MEETING
December 29, 2003
- Medical Fees Remain Unchanged
December 29, 2003
- Meet the Leaders (28)
December 29, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…